Safety and Efficacy Study of MT-2990 in Women With Endometriosis
Clinical trial NCT03840993 · COMPLETED
Trial details
- NCT number
- NCT03840993
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2021-05-13
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.